Wayland Group Enters into a Letter of Intent to Sell 49.9% of International Business to International Cannabis Corp.
15 January 2019 - 11:16PM
InvestorsHub NewsWire
Wayland Group Enters into a Letter of
Intent to Sell 49.9% of International Business to International
Cannabis Corp.
Toronto, ON -- January 15, 2019 --
InvestorsHub NewsWire -- Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the
“Company”) is pleased to announce that, pursuant to the Company’s
previously announced strategic review, it has entered into a Letter of Intent to sell
49.9% of the Company’s international portfolio of assets to
International Cannabis Corp (“ICC”). Wayland will receive
300,000,000 shares of ICC that trade under the symbol WRLD.U on the
Canadian Securities Exchange, at a deemed price of USD $0.43 per
share (the “Issue Price”). Based on the Issue Price, once complete
this transaction will value Wayland’s international business at
approximately
USD$258,000,000.
Additional Transaction
Details
Upon consummation of
the proposed
transaction:
-
Wayland will sign a
three-year supply agreement with ICC that will supply ICC with
10,000kg of EU-GMP certified product per year, for a total of
30,000kg during the
term
-
ICC will gain access to
Wayland’s German advisory board to help with production and
distribution strategies, branding campaigns, as well as the
continued penetration of new cannabis and CBD markets and verticals
through Cosmos
Holdings
-
Wayland’s international
business will be held in a subsidiary which will be jointly owned
by Wayland and ICC
-
ICC shares will not be
distributed to Wayland shareholders for a period of not less than
six months from the closing date of the
transaction.
This transformational event
for Wayland shareholders affords them the opportunity to unlock the
value in the Company’s international portfolio and to gain exposure
to ICC’s international business. Based on yesterday’s closing price
of Wayland, this transaction will value the international assets at
a 13.3% premium to the current market value of Wayland’s entire
global business and a 32.6% premium to the 20-day VWAP
(volume-weighted average price). The current intention is to spin
out the 300,000,000 ICC shares to WAYL shareholders at the
appropriate time after the six-month holding
period.
Subject to
developments in the strategic review, the Company will continue to
operate its Canadian business supplying its current medical patient
base and the Canadian Provinces. Wayland’s state-of-the-art,
purpose-built cannabis production facility in Langton, Ontario will
be fully operational in
2019.
“The proposed
transaction would provide Wayland and our shareholders with
exposure to an unparalleled portfolio of international assets to
address the ever-expanding global legalization of medical cannabis
with operations in countries with a total population of just over
390 million people and access to international markets that exceed
a billion people. This transaction ascribes value to our
international assets that is in line with our expectations as the
value of our international assets is now greater than the entire
company’s present market capitalization. The transaction also
provides an opportunity at the appropriate time to fully integrate
our international operations with ICC’s to cover all aspects of the
value chain, including medical plant production, extraction, active
pharmaceutical ingredient isolation, finished dose manufacturing,
and distribution.” Stated Wayland CEO, Ben Ward.
The transaction is
expected to close on or around March 1, 2019 and is subject to a
number of conditions including certain regulatory, stock exchange
and securityholder approvals and other conditions, completion of
satisfactory due diligence by ICC and Wayland, Wayland and ICC each
receiving fairness opinions, the completion of a reorganization of
Wayland’s international assets and the entering into a definitive
agreement.
This Transaction is subject to a finder's
fee.
About Wayland
Group
Wayland is a vertically integrated cultivator
and processor of cannabis. The Company was founded in 2013 and is
based in Burlington, Ontario, Canada and Munich, Germany, with
production facilities in Langton, Ontario where it operates a
cannabis cultivation, extraction, formulation, and distribution
business under federal licenses from the Government of Canada. The
Company also has production operations in Dresden, Saxony, Germany,
Regensdorf, Switzerland, Allesandria, Piedmont, Italy and Ibague,
Colombia. Wayland will continue to pursue new opportunities
globally, including the consummation of its previously announced
transactions in the United Kingdom, Australia and Argentina, in its
effort to enhance lives through
cannabis.
Forward Looking
Information
This news release
includes forward-looking information and statements, which may
generally be identified by the use of the words “will”,
“intention”, “expects”, “is expected to”, “subject to”, and
variations or similar expressions and which include, but are not
limited to, information and statements regarding or inferring the
future business, operations, financial performance, prospects, and
other plans, intentions, expectations, estimates, and beliefs of
the Company. Such statements include those relating to the terms of
the proposed transaction, the value of Wayland’s international
business, its entering into a supply agreement with ICC and the
terms thereof, the combined presence of the companies, and the
integration of Wayland’s operations team into ICC’s existing
operations, certain expected effects of the transaction, the
anticipated date for entering into a definitive agreement and
closing the transaction, the nature and satisfaction of certain
conditions to completion, the Company’s expectations regarding the
operation of its Canadian business going forward and the
anticipated timeline for the completion of the Company’s Langton
facility. Forward-looking information and statements involve and
are subject to assumptions and known and unknown risks,
uncertainties, and other factors which may cause actual events,
results, performance, or achievements of the Company to be
materially different from future events, results, performance, and
achievements expressed or implied by forward-looking information
and statements herein. Such assumptions, risks, uncertainties and
other factors include, but are not limited to, that the proposed
transaction will be completed on the terms and timelines
anticipated by the Company or at all, that the consummation of the
proposed transaction will help to unlock the value of the Company’s
international portfolio in the manner anticipated or at all, that
the value of the ICC common shares received by the Company in
connection with the transaction will not decrease in value, that
all necessary stock exchange, securityholder regulatory and other
approvals will be received in connection with the proposed
transaction on the timelines anticipated or at all, that all other
conditions to closing will be satisfied in the manner and on the
timelines anticipated, that the integration of Wayland’s existing
operations team into ICC and ICC’s access to Wayland’s German
advisory board will have the anticipated benefits for both
companies, that Wayland will be able to distribute the ICC common
shares received pursuant to the proposed transaction to Wayland’s
shareholders in a cost effective manner and on the timelines
anticipated and that the Company will be able to continue to
operate its existing Canadian business as planned and certain
matters relating to the conduct and outcome of the Company’s
ongoing strategic review. Although the Company believes that any
forward-looking information and statements herein are reasonable,
in light of the use of assumptions and the significant risks and
uncertainties inherent in such information and statements
(including the risk that some or all of the assumptions made by the
Company may prove to have been incorrect), there can be no
assurance that any such forward-looking information and statements
will prove to be accurate, and accordingly readers are advised to
rely on their own evaluation of such risks and uncertainties and
should not place undue reliance upon such forward-looking
information and statements. In particular, the completion of the
proposed transaction is subject to the satisfaction of a number of
conditions and uncertainties (including the completion of
satisfactory due diligence, and the negotiation of definitive
agreements) and the Company can offer no assurance that the
proposed transaction will be completed on the terms, conditioned
and timelines anticipated or at all, nor can any assurance be
offered that the Company’s strategic review will result in any
other transaction in respect of the Company’s international assets
or otherwise being identified or successfully completed. Any
forward-looking information and statements herein are made as of
the date hereof, and except as required by applicable laws, the
Company assumes no obligation and disclaims any intention to update
or revise any forward-looking information and statements herein or
to update the reasons that actual events or results could or do
differ from those projected in any forward looking information and
statements herein, whether as a result of new information, future
events or results, or otherwise, except as required by applicable
laws.
The Canadian
Securities Exchange has not reviewed, approved or disapproved the
content of this news release
For more information
about Wayland, please visit our website at www.waylandgroup.com
Contact
Information:
Investor
Relations
Graham
Farrell
VP,
Communications
Graham.Farrell@waylandgroup.com
647-643-7665
Media
Inquiries: media@waylandgroup.com
Corporate Headquarters
(Canada)
Wayland Group Corp.
(Toronto)
845 Harrington Court,
Unit 3
Burlington Ontario L7N
3P3
Canada
289-288-6274
European Headquarters
(Germany)
Maricann
GmbH
Thierschstrasse 3,
80538 Munchen,
Deutschland
Wayland (CE) (USOTC:MRRCF)
Historical Stock Chart
From Nov 2024 to Dec 2024
Wayland (CE) (USOTC:MRRCF)
Historical Stock Chart
From Dec 2023 to Dec 2024
Real-Time news about Wayland Group Corporation (CE) (OTCMarkets): 0 recent articles
More Wayland Group Corp. News Articles